chemotherapy

(redirected from Chemotherapy-induced nausea and vomiting)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to chemotherapy

the use of chemical agents to treat or control disease (or mental illness)

References in periodicals archive ?
for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer and of post-operative nausea and vomiting (PONV), and of the original nimesulide, a non-steroidal anti-inflammatory drug http://en.
Chemotherapy-induced nausea and vomiting is a common problem that can severely impair a patient's quality of life.
More than half of cancer patients who undergo chemotherapy suffer acute and/or repeated chemotherapy-induced nausea and vomiting, according to Eisai.
Nausea and vomiting remain a significant clinical problem: Trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices.
There is a need to study a new option for chemotherapy-induced nausea and vomiting prevention, despite the progress that has been made thus far," said Kenichi Nomoto, Ph.
Pharmacological treatment of chemotherapy-induced nausea and vomiting (CINV) has focused on blocking these receptors using agents such as antihistamines (e.
About Chemotherapy-Induced Nausea and Vomiting (CINV) CINV is estimated to affect 85% of cancer patients undergoing chemotherapy and can result in a delay or discontinuation of chemotherapy treatments.
OB), a specialty pharmaceutical company, today announced additional data from the Company's Phase 3 study of APF530 for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Charleston's product pipeline currently seeks to address unmet needs in Opioid-Induced Nausea and Vomiting (OINV), Postoperative Nausea and Vomiting (PONV), Chemotherapy-Induced Nausea and Vomiting (CINV), Radiation-Induced Nausea and Vomiting (RINV), and Migraine-Induced Nausea and Vomiting (MINV).
Cancer patients suffering from chemotherapy-induced nausea and vomiting (CINV) will have to wait for the pharmaceuticals market to catch up with their needs, new drug research from industry analysis specialist GlobalData has found.
The most commonly reported adverse reactions in Aloxi chemotherapy-induced nausea and vomiting trials include headache (9%) and constipation (5%).
Rolapitant is a Phase 3-ready neurokinin-1 (NK1) receptor antagonist being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Helsinn is the worldwide licensor of palonosetron, a second generation 5-HT3 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer and of post-operative nausea and vomiting (PONV), and of the original nimesulide, a non-steroidal anti-inflammatory drug (NSAID) distributed in more than 50 countries worldwide.